Clene Inc. (NASDAQ: CLNN) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $23.00 price target on the stock.
Clene Improves Cash Position and Runway by Securing New Debt Facility to Pay Off Existing Senior Loan [Yahoo! Finance]
Clene Improves Cash Position and Runway by Securing New Debt Facility to Pay Off Existing Senior Loan
IBN Coverage: Clene (NASDAQ: CLNN) Advances CNM-Au8 in ALS With FDA Guidance on Accelerated Approval Pathway [Yahoo! Finance]
Clene Inc. (NASDAQ: CLNN) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $23.00 price target on the stock.